What is Viridian Therapeutics, Inc.'s AOCI?

Viridian Therapeutics, Inc. (VRDN) reported AOCI of -$558K in Q1 2026.

How has Viridian Therapeutics, Inc.'s AOCI changed year-over-year?

Viridian Therapeutics, Inc.'s AOCI decreased by 327.8% year-over-year, from $245K to -$558K.

What is the long-term trend for Viridian Therapeutics, Inc.'s AOCI?

Over 5 years (2020 to 2025), Viridian Therapeutics, Inc.'s AOCI has grown at a 123.6% compound annual growth rate (CAGR), from -$8K to $447K.

Accumulated gains and losses bypassing the income statement — unrealized investment gains/losses, currency translation, pension adjustments, and hedge results.

Viridian Therapeutics, Inc. VRDN AOCI

AOCI at other companies

AmgenAMGN

-$190M+17.7%

Immunovant, Inc.IMVT

$730K-50.0%

ANI PharmaceuticalsANIP

$479K-86.7%

Vir Biotechnology, Inc.VIR

-$3.48M-76.4%

Nektar TherapeuticsNKTR

-$1.03M-2,751%

Syndax PharmaceuticalsSNDX

$11K-97.9%

Other financials

Income statement

See full

Revenue$141.0K+95.8%

Operating income-$116.2M-23.8%

Net income-$104.9M-20.7%

EPS (diluted)-$1.15-5.5%

Balance sheet

See full

Cash & equivalents$176.3M+51.7%

Total debt$36.8M+59.4%

Total equity$636.0M+5.2%

Total assets$789.0M+19.4%

Cash flow

See full

Operating cash flow-$119.7M-29.1%

CapEx$23.0K-73.3%

Free cash flow-$119.7M-29.0%

Valuation

See full

Market cap$1.91B+82.0%

Enterprise value$1.77B+85.0%

P/S26.9×-3,445×

Profitability

See full

Gross margin36.3%—

Operating margin-543.9%-271pp

Net margin-508.5%-254pp

FCF margin-428.4%-214pp

Returns & leverage

See full

Return on equity-58.1%+7.9pp

Debt / equity0.1×0.0×

Current ratio15.1×-4.3×

Where this comes from

Reported directly by Viridian Therapeutics, Inc. in its filing.

Tagged under the XBRL concept us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax.

The official record: Viridian Therapeutics, Inc.’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →

Ask your AI about Viridian Therapeutics, Inc.'s aoci.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Viridian Therapeutics, Inc.'s AOCI?: Viridian Therapeutics, Inc. (VRDN) reported AOCI of -$558K in Q1 2026.
How has Viridian Therapeutics, Inc.'s AOCI changed year-over-year?: Viridian Therapeutics, Inc.'s AOCI decreased by 327.8% year-over-year, from $245K to -$558K.
What is the long-term trend for Viridian Therapeutics, Inc.'s AOCI?: Over 5 years (2020 to 2025), Viridian Therapeutics, Inc.'s AOCI has grown at a 123.6% compound annual growth rate (CAGR), from -$8K to $447K.
What does AOCI mean?: Accumulated gains and losses bypassing the income statement — unrealized investment gains/losses, currency translation, pension adjustments, and hedge results.